Publication | Closed Access

Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors

ThrombosisVenous ThrombosisCancer ImmunosurveillanceMedicineImmune Checkpoint InhibitorsImmunologyPathologyImmune Checkpoint InhibitorKhorana ScoreLung Cancer PatientsCancer TreatmentLung CancerImmunotherapyOncologyTumor Microenvironment